Literature DB >> 500299

Serum and ultradiafiltrate middle molecules in hemodialysed patients.

P Bozek, J Erben, J Zahradnik, R Dzúrik.   

Abstract

The gel filtration technique was used for the fractionation of middle molecular substances (MMS) in plasma from conservatively treated patients, from dialysed patients with renal failure and in the ultradiafiltrate from dialysed ones. The following observations were made: 1. MMS accumulate in the plasma of conservatively treated patients in chronic renal failure. 2. The accumulation of MMS in dialysed patients is even higher. 3. The elimination of the most important MMS in the ultradiafiltrate is excellent. 4. It is concluded that hemofiltration and ultradiafiltration are indicated also for the removal of MMS, namely in the case of clinical complications which cause a further accumulation of MMS.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500299     DOI: 10.1007/bf02081963

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  10 in total

1.  Middle molecules in uremic serum, urine and dialysis fluid.

Authors:  L Migone; P Dall'taglio; C Buzio
Journal:  Clin Nephrol       Date:  1975       Impact factor: 0.975

2.  Gel chromatography on Sephadex gels with narrow particle size distribution obtained by dry elutriation.

Authors:  R Ekman; B G Johansson; U Ravnskov
Journal:  Anal Biochem       Date:  1976-02       Impact factor: 3.365

3.  Uremic middle molecules.

Authors:  J Bergström; P Fürst
Journal:  Clin Nephrol       Date:  1976-04       Impact factor: 0.975

4.  Determination of endogenous middle molecules in normal and uremic body fluids.

Authors:  P Fürst; L Zimmerman; J Bergström
Journal:  Clin Nephrol       Date:  1976-04       Impact factor: 0.975

5.  [Mean molecular substance volume in the sera of patients after kidney transplant operation (author's transl)].

Authors:  P Bozek; R Dzúrik; H Danĕková; J Reznícek; V Zvara
Journal:  Cas Lek Cesk       Date:  1977-01-14

6.  Investigation of the clearance and generation rate of endogenous peptides in normal subjects and uremic patients.

Authors:  J H Peters; F A Gotch; M Keen; B J Berridge; W R Chao
Journal:  Trans Am Soc Artif Intern Organs       Date:  1974

7.  Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated haemodialysis. I. Preliminary characteristics.

Authors:  Z Hanicki; M Sarnecka-Keller; A Klein; K Slizowska
Journal:  Clin Chim Acta       Date:  1974-07-15       Impact factor: 3.786

8.  Blood level of middle molecular substances during uraemia and haemodialysis.

Authors:  R Dzúrik; P Bozek; J Reznícek; A Oborníková
Journal:  Proc Eur Dial Transplant Assoc       Date:  1973

9.  The genesis of the square meter-hour hypothesis.

Authors:  A L Babb; R P Popovich; T G Christopher; B H Scribner
Journal:  Trans Am Soc Artif Intern Organs       Date:  1971

10.  Ninhydrin-positive substances in serum and urine of patients with chronic uraemia.

Authors:  J Adam; R Dzúrik; E Valovicová
Journal:  Clin Chim Acta       Date:  1972-01       Impact factor: 3.786

  10 in total
  2 in total

1.  Middle molecular substances in acute renal failure.

Authors:  M Mydlík; V Spustová; R Dzúrik; K Derzsiová
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

2.  Peritoneal dialysability of "uraemic substances".

Authors:  I Taraba; V Spustova; A Balás-Eltes; R Dzurik; G Y Petrányi
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.